Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation (CYTER)
Cardiac Arrest, Extracorporeal Circulation, Extracorporeal Membrane Oxygenation
About this trial
This is an interventional treatment trial for Cardiac Arrest focused on measuring Extracorporeal Circulation, Extracorporeal Membrane Oxygenation, Cytokine Adsorption, Post-Cardiac Arrest Syndrome, Cardiac Arrest, Cardio-Pulmonary Resuscitation
Eligibility Criteria
Inclusion Criteria:
- All patients admitted to our ICU after successful CPR undergoing eCPR will be included in the trial.
Exclusion Criteria:
- The single exclusion criteria for the trial is, if decision has been made before admission to our ICU to terminate treatment within the next 24 hours.
Sites / Locations
- University Clinic Freiburg
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
intervention group: eCPR + CytoSorb
control group: eCPR - CytoSorb
In addition to standard treatment in patients undergoing eCPR in the intervention group the CytoSorb removal column will be added to the ECLS-system (intervention: CytoSorb removal column in eCPR).
Patients in the control group will receive standard treatment established for eCPR patients on our ICU. This standard treatment includes, among others, targeted temperature management (TTM) for the first 72 hours. For the use of ECLS as well as TTM we are following well established standard operating procedures (control: standard eCPR (va-ECMO)).